PharmaDossierIndependent biopharma information, guidance, and source-cited analysis.

PHARMApharmadossier

Topic

Label Warnings

Boxed warnings, precautions, contraindications, monitoring requirements, and commercial implications of safety language.

4 articles·Lives underEvidence Approvals·Last updated 2026-06-14

Policy· June 14, 2026 · 13 min read

How to read an FDA FAERS report: what spontaneous reporting can and cannot prove

By Ran Chen#Real-World Evidence #Postmarketing Requirements #Label Warnings

Evidence· June 14, 2026 · 14 min read

GLP-1 receptor agonists in FAERS: adverse-event reporting by the numbers

By Ran Chen#Real-World Evidence #Label Warnings #Postmarketing Requirements

Policy· June 14, 2026 · 12 min read

How to read an FDA drug label on DailyMed: indication scope, boxed warnings, and PA

By Ran Chen#Label Warnings #Boxed Warning #Prior Authorization

Evidence· June 14, 2026 · 12 min read

JAK inhibitors in FAERS: 242,498 adverse-event reports by the numbers

By Ran Chen#Real-World Evidence #Label Warnings #Postmarketing Requirements